Kenneth B. Adler

Corporate Officer/Principal chez North Carolina State University

Consumer Services

Health Technology

Postes actifs de Kenneth B. Adler

Sociétés	Poste	Début	Fin
North Carolina State University	Corporate Officer/Principal	-	-

Sociétés	Poste	Début	Fin
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Directeur Technique/Scientifique/R&D	25/02/2002	-
	Fondateur	20/01/2010	-

University of Vermont

Doctorate Degree

Internationale

Etats-Unis

Opérationnelle

Chief Tech/Sci/R&D Officer	1
Founder	1
Corporate Officer/Principal	1

Sectorielle

Consumer Services	3
Health Technology	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Health Technology

Entreprise privées

Health Technology